Literature DB >> 33704391

Targeting the p-D-C: easy as C-D-1-2-3?

Naveen Pemmaraju1.   

Abstract

Year:  2021        PMID： 33704391      PMCID： PMC7955405          DOI： 10.1182/blood.2020008745

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Authors:  C T Jordan; D Upchurch; S J Szilvassy; M L Guzman; D S Howard; A L Pettigrew; T Meyerrose; R Rossi; B Grimes; D A Rizzieri; S M Luger; G L Phillips
Journal:  Leukemia       Date:  2000-10       Impact factor: 11.528

2.  DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance.

Authors:  Katsuhiro Togami; Timothy Pastika; Jason Stephansky; Mahmoud Ghandi; Amanda L Christie; Kristen L Jones; Carl A Johnson; Ross W Lindsay; Christopher L Brooks; Anthony Letai; Jeffrey W Craig; Olga Pozdnyakova; David M Weinstock; Joan Montero; Jon C Aster; Cory M Johannessen; Andrew A Lane
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

3.  Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

Authors:  Naveen Pemmaraju; Andrew A Lane; Kendra L Sweet; Anthony S Stein; Sumithira Vasu; William Blum; David A Rizzieri; Eunice S Wang; Madeleine Duvic; J Mark Sloan; Sharon Spence; Shay Shemesh; Christopher L Brooks; John Balser; Ivan Bergstein; Jeffrey E Lancet; Hagop M Kantarjian; Marina Konopleva
Journal:  N Engl J Med       Date:  2019-04-25       Impact factor: 91.245

4.  Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Narittee Sukswai; Phyu P Aung; C Cameron Yin; Shaoying Li; Wei Wang; Sa A Wang; Victor Ortega; Kirill Lyapichev; Priyadharsini Nagarajan; Rasha Alfattal; Evgeniya Angelova; Zhenya Tang; Sanam Loghavi; Rashmi Kanagal-Shamanna; Roberto N Miranda; Naveen Pemmaraju; Kapil Bhalla; Marina Konopleva; L Jeffrey Medeiros; Joseph D Khoury
Journal:  Am J Surg Pathol       Date:  2019-10       Impact factor: 6.394

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

6.  Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.

Authors:  Wenbin Xiao; Alexander Chan; Michael R Waarts; Tanmay Mishra; Ying Liu; Sheng F Cai; Jinjuan Yao; Qi Gao; Robert L Bowman; Richard P Koche; Isabelle S Csete; Nicole L DelGaudio; Andriy Derkach; Jeeyeon Baik; Sophia Yanis; Christopher A Famulare; Minal Patel; Maria E Arcila; Maximilian Stahl; Raajit K Rampal; Martin S Tallman; Yanming Zhang; Ahmet Dogan; Aaron D Goldberg; Mikhail Roshal; Ross L Levine
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113
  6 in total
  2 in total

1.  Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies.

Authors:  George S Laszlo; Johnnie J Orozco; Allie R Kehret; Margaret C Lunn; Jenny Huo; Donald K Hamlin; D Scott Wilbur; Shannon L Dexter; Melissa L Comstock; Shyril O'Steen; Brenda M Sandmaier; Damian J Green; Roland B Walter
Journal:  Leukemia       Date:  2022-04-26       Impact factor: 12.883

2.  Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

Authors:  Siba El Hussein; Mariko Yabe; Wei Wang; Naveen Pemmaraju; Sanam Loghavi; Fatima Zahra Jelloul; Hong Fang; L Jeffrey Medeiros; W Richard Burack; Andrew G Evans; Jane L Liesveld; John M Bennett
Journal:  EJHaem       Date:  2022-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.